C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2002
10/30/2002	CN1377357A Pyrazolo [4,3-d] pyrimidines
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002	CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002	CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002	CN1093541C Metalloporphyrin and producing process thereof
10/29/2002	US6472528 Synthesis of substituted pyrazolopyrimidines
10/29/2002	US6472525 Hexaazaisowurtzitane derivative and method for producing the same
10/29/2002	US6472523 Wherein m is an atom or group of atoms capable of bonding to the central cavity of a phthalocyanine molecule, wherein axial ligands optionally can be attached to metal
10/29/2002	US6472425 Methods for treating female sexual dysfunctions
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472416 Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002	US6472402 Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
10/29/2002	US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002	US6472389 Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect
10/29/2002	US6472388 Psychotherapeutic agents.
10/29/2002	US6472385 Compositions and methods to enhance cancer chemotherapy in p53 defective tumors
10/29/2002	CA2273180C Method of preparation of physostigmine carbamate derivatives from eseroline ethers
10/24/2002	WO2002083693A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
10/24/2002	WO2002083686A2 Processes for large scale production of tetrapyrroles
10/24/2002	WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	WO2002083684A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083683A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083682A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083681A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	WO2002083680A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083679A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083678A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083677A1 6-(2-chloro-6-fluoro-phenyl)-triazolopyrimidines
10/24/2002	WO2002083676A1 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides
10/24/2002	WO2002083675A2 Inhibitors of akt activity
10/24/2002	WO2002083674A2 Compositions containing imidazotriazinone for nasal application
10/24/2002	WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083152A1 Activation of natural killer cells by adenosine a3 receptor agonists
10/24/2002	WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083140A1 Inhibitors of akt activity
10/24/2002	WO2002083139A1 Inhibitors of akt activity
10/24/2002	WO2002083064A2 A method of treating cancer
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002036596A3 CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
10/24/2002	WO2002030931A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
10/24/2002	US20020156285 Novel herbicides
10/24/2002	US20020156278 Process for the preparation of pure triethylenediamine (TEDA)
10/24/2002	US20020156275 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156079 Antiulcer, antibacterial activity against Helicobacter pylori
10/24/2002	US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/24/2002	US20020154535 High density non-volatile memory device
10/24/2002	US20020152558 Compositions for dyeing keratinous fibers comprising pyrazoloazoles; their use in dyeing as oxidation base and dyeing process; and novel pyrazoloazoles
10/24/2002	CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	CA2443870A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	CA2443805A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	CA2443696A1 5-halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides
10/24/2002	CA2443639A1 Compositions containing imidazotriazinone for nasal application
10/24/2002	CA2443568A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443567A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereofas tocolytic oxytocin receptor antagonists
10/24/2002	CA2443566A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443565A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	CA2443564A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	CA2443490A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	CA2442264A1 A method of treating cancer
10/24/2002	CA2435488A1 Processes for large scale production of tetrapyrroles
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251130A1 Fused purine derivatives
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250339A1 Porphyrins and related compounds
10/23/2002	EP1250338A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors
10/23/2002	EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002	EP1250140A2 Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound
10/23/2002	EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002	EP1000063B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
10/23/2002	EP0975698B1 Phthalocyanine ink-jet dyes
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002	CN1376157A Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
10/23/2002	CN1376156A Benzodiazepin derivatives, the production and use thereof
10/23/2002	CN1375494A Iso-indolo-indolone compound, their preparation methods and drug compositions comprising the same
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/22/2002	US6469437 Highly transparent organic light emitting device employing a non-metallic cathode
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469174 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469017 Method of inhibiting interleukin-12 signaling
10/22/2002	US6469012 Pyrazolopyrimidinones for the treatment of impotence
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/22/2002	US6468999 Treating anxiety, depression and other central nervous system disorders in humans and animals
10/22/2002	US6468713 Phthalocyanine compounds, process for producing the same, and near infrared absorbent comprising the same
10/22/2002	CA2227264C Amine acid salt compounds and process for the production thereof
10/22/2002	CA2218477C Rna photocleavage using texaphyrins
10/17/2002	WO2002081475A1 Jun kinase inhibitors
10/17/2002	WO2002081474A1 Triazolophthalazine / quinoline / isoquinoline derivatives which are ligands for gaba-a receptors containing the alpha 5 subtype
10/17/2002	WO2002081473A1 Substituted azoloazin(thi)ones
10/17/2002	WO2002081448A1 Benzamidine derivative
10/17/2002	WO2002081445A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
10/17/2002	WO2002081443A1 Novel guanidino compounds
10/17/2002	WO2002080957A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents

1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 573